SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?


To: Vector1 who wrote (159)8/29/1998 8:41:00 PM
From: Andy Patton  Read Replies (1) | Respond to of 359
 
Thanks for the doubts on AFFX. I agree that INCY at 20 looks better than AFFX at 18. INCY already is profitable--and I like the fact that buying INCY now means that (because of their acquisitions and equity stakes) I'm buying a stake in the former Synteni, and Genome Systems, plus Combion plus investments in Netgenics and Oncor Med, plus the latest British foray as well.

Good luck.

-Andy Patton